Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (725)	8/24/2001 2:31:51 PM
From: Raymond Duray	Read Replies (1) \| Respond to of 746

Hi Bob, I find it interesting that when the press can't really assess the science involved, it turns the issue into a horse race. I'm betting that Collins and Venter are closer to the truth than the various cast of characters who are promoting the notion of a much larger number of genes. There's so much at stake for Haseltine at HGSI or for Novartis to keep the investing public titillated with the "story" of copious new discoveries to made by..... HGSI and Novartis... I'm skeptical of their motivation, as you can tell, though when I've brought this matter up with a couple of researchers, they suggest that reasonable minds can differ on the matter. I'm keeping an open mind. I guess we'll know the answer soon enough. Have a great weekend, Ray :)